MOL Q2 FY27 Results & Earnings Analysis
Sentiment: Neutral (Confidence: medium)
Earnings Summary
Meghmani Organics reported 18% YoY standalone revenue growth in Q2 FY27, but margins were pressured by sharp input and logistics cost increases, with EBITDA flat YoY. The agrochemical segment is expected to grow double digits with 15-17% EBITDA margins long-term, while pigments remain stable. Key concerns include elevated trade receivables and near-term margin volatility.
Management Tone
- Prepared Remarks: Good — Prepared remarks highlighted 18% YoY revenue growth, 6% net profit growth, and strategic progress like NCLT approval for amalgamation and new product launches. Management confidently outlined growth prospects despite near-term cost pressures.
- Q&A Session: Neutral — Analysts probed margin decline, receivables increase, and regional demand weakness. Management responses were cautious, citing volatility and challenges, with limited quantification on some future outlooks.
Revenue Growth Drivers
- Volume growth and better product mix
- Currency depreciation (USD/INR)
- Weak European demand for pigments
Growth vs Margin Focus
Management aims to sustain revenue growth momentum while improving profitability through product mix and cost efficiencies.
About Meghmani Organics Limited
Meghmani Organics Limited (MOL) is listed on NSE. View the latest earnings analysis, AI-powered insights, and sentiment data on StockMirror.